EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Material Safety of Styrene- Block -Ethylene/Butylene- Block -Styrene Copolymers Used for Cardiac Valves: 6-Month In Vivo Results from a Juvenile Sheep Model

Raimondo Ascione iD, Joanna R Stasiak, Daniel Baz-Lopez, Marta Serrani, Geoff D Moggridge

European Journal of Cardio-Thoracic Surgery · 2025

DOI: 10.1093/ejcts/ezaf266 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Raimondo Ascione und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bristol Medical School and Translational Biomedical Research Centre, Faculty of Health and Life Science, University of Bristol, Bristol BS2 8HW, Unit…. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Polymers, Mitral Valve, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, National Institute Health Research invention for innovation product development Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To assess the in vivo 6-month safety of styrene-block-ethylene/butylene-block-styrene (SEBS) block copolymers material used to make cardiac valves.

Methods

Research-grade mitral valve prototypes made from SEBS29/SEBS20 copolymers (n = 7; 3 with heparin-coating) were implanted in juvenile sheep under cardiopulmonary bypass and kept for 6 months. No vitamin K antagonists were used. Anticoagulation included enoxaparin 1 mg/kg SC twice/day from day 1 until day 120 along with clopidogrel 300 mg once/day with food from day 1 until sacrifice. Safety measures included SEBS-related calcification, degradation, haemolysis, cytotoxicity, clinical pathology (biochemistry, complete blood count, coagulation), structural integrity, damage to surrounding tissue, overall animal health, and device embolization and function.

Results

Surgery was feasible in all cases. Four animals reached the final 180 ± 5 days timepoint, while 1 needed non-SEBS related sacrifice on day 2, 1 suffered non-SEBS related death on day 81, and 1 needed sacrifice on day 169 due to prototype dysfunction. High-resolution X-ray, spectroscopy and histology showed absence of SEBS calcification, while gel permeation chromatography confirmed no SEBS degradation at 6 months. At histology, there was no SEBS-related calcification, thrombosis, cytotoxic or neoplastic degeneration, and no damage of the cardiac and downwards organs. Blood testing showed no haemolysis, while clinical pathology and animal health remained within normal reference intervals. The function of the research-grade mitral prototypes was clinically acceptable. The use of heparin-coating did not add benefit.

Conclusions

This preclinical in vivo study in juvenile sheep confirms the 6-month safety of SEBS29/SEBS20 material used to make cardiac valves. A future early feasibility study is warranted to confirm long-term durability, haemocompatibility, and function in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve ProsthesisPolymersMitral ValveHeart Valve Prosthesis ImplantationAnimalsSheepMaterials TestingProsthesis DesignFemale

Stichwörter der Autor:innen

SEBS co-polymerscalcificationcardiac valvesmaterial safetypreclinical testing

Substanzen

Polymers

Autor:innen und Institutionen

  • Bristol Medical School and Translational Biomedical Research Centre, Faculty of Health and Life Science, University of Bristol, Bristol BS2 8HW, United Kingdom.
  • Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB3 0AS, United Kingdom.
  • Department of Engineering, Durham University, DH1 3LE, Durham, UK.

ORCID-Profile: Raimondo Ascione

Förderung

  • British Heart Foundation
  • National Institute Health Research invention for innovation product development Award

Zitieren

APA

Ascione, R., Stasiak, J. R., Baz-Lopez, D., Serrani, M., & Moggridge, G. D. (2025). Material Safety of Styrene- Block -Ethylene/Butylene- Block -Styrene Copolymers Used for Cardiac Valves: 6-Month In Vivo Results from a Juvenile Sheep Model. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf266

Vancouver

Ascione R, Stasiak JR, Baz-Lopez D, Serrani M, Moggridge GD. Material Safety of Styrene- Block -Ethylene/Butylene- Block -Styrene Copolymers Used for Cardiac Valves: 6-Month In Vivo Results from a Juvenile Sheep Model. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf266

BibTeX
@article{Ascione2025,
  author = {Ascione, Raimondo and Stasiak, Joanna R and Baz-Lopez, Daniel and Serrani, Marta and Moggridge, Geoff D},
  title = {Material Safety of Styrene- Block -Ethylene/Butylene- Block -Styrene Copolymers Used for Cardiac Valves: 6-Month In Vivo Results from a Juvenile Sheep Model},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  doi = {10.1093/ejcts/ezaf266}
}
Kostenlos starten →